Method for producing radiopharmaceutical composition
AssigneesNihon Medi-Physics Co., Ltd., National University Corporation Hokkaido University
InventorsMasato Kiriu, Soichi Nakamura, Yuji Kuge, Norifumi Abo
Life of this patent
Estimating the term…
Abstract
A simple method for producing a clinically applicable radiopharmaceutical composition containing 1-(2,2-dihydroxymethyl-3-[18F]fluoropropyl)-2-nitroimidazole ([18F]DiFA) or a salt thereof as an active ingredient, is provided which includes a synthesis step of obtaining a crude product of [18F]DiFA from a labeling precursor compound for [18F]DiFA; and a purification step of purifying the crude product, in which the purification step includes purifying [18F]DiFA using two or more different types of reverse phase solid phase extraction cartridges.
Claims5
A method for producing a radiopharmaceutical composition containing a radioactive fluorine-labeled compound represented by the following general formula (1) or a salt thereof as an active ingredient, comprising:
- a synthesis step of obtaining a crude product of the radioactive fluorine-labeled compound from a labeling precursor compound represented by the following formula (2);
- and
- purification steps of purifying the radioactive fluorine-labeled compound, wherein
- the purification steps include:
- a first purification step using a first reverse phase solid phase extraction cartridge filled with a poly(divinylbenzene-co-N-vinylpyrrolidone) polymer;
- and
- a second purification step using a second reverse phase solid phase extraction cartridge filled with octadecylsilylated silica gel,
- wherein the first purification step includes:
- adsorbing the radioactive fluorine-labeled compound on the first reverse phase solid phase extraction cartridge;
- washing the first reverse phase solid phase extraction cartridge on which the radioactive fluorine-labeled compound has been adsorbed with a washing liquid;
- and
- eluting the radioactive fluorine-labeled compound from the first reverse phase solid phase extraction cartridge by allowing an eluent to pass through the first reverse phase solid phase extraction cartridge, wherein
- the washing liquid is an ethanol aqueous solution containing 4 to 10% by volume ethanol, and
- the eluent is an ethanol aqueous solution containing 15% by volume or more ethanol,
- wherein X represents a radioactive fluorine atom;
- wherein P1 and P2 independently or together represent a hydroxy group-protecting group, and L represents a tosyl group.
Dependencies are inferred from the claim text.